{
    "clinical_study": {
        "@rank": "78894", 
        "arm_group": [
            {
                "arm_group_label": "Bonebridge", 
                "arm_group_type": "Active Comparator", 
                "description": "Implantation with a Bonebridge"
            }, 
            {
                "arm_group_label": "Bone Anchored Hearing Aid", 
                "arm_group_type": "Active Comparator", 
                "description": "Implantation with a Bone Anchored Hearing Aid"
            }
        ], 
        "brief_summary": {
            "textblock": "The Bonebridge is a new bone conducting implantable hearing aid. The investigators plan to\n      randomize patients to receive either the Bonebridge or a conventional bone conducting\n      hearing device. The investigators will then compare the surgical and audiological outcomes\n      of the two groups."
        }, 
        "brief_title": "A Randomised Controlled Trial Comparing Bone Anchored Hearing Aid With Bonebridge", 
        "completion_date": {
            "#text": "January 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Hearing Loss, Conductive", 
            "Bone Conduction Deafness"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Deafness", 
                "Hearing Loss", 
                "Hearing Loss, Conductive"
            ]
        }, 
        "detailed_description": {
            "textblock": "The new Bonebridge fully implanted, except for an external sound processor. It does not have\n      any percutaneous parts like the Bone Anchored Hearing Aid. The investigators believe that\n      this may improve wound healing and reduce problems with wound infection and skin overgrowth\n      seen in Bone Anchored Hearing Aids.\n\n      There may also be audiological improvements by the use of the Bonebridge as the physical\n      separation of the vibrating part from the sound processor should reduce feedback. The\n      company also claims other audiological improvements in the Bonebridge.\n\n      The investigators wish to demonstrate whether this is actually the case by performing a\n      study directly comparing the outcomes of the two groups."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Conductive Hearing Loss within criteria for Bonebridge\n\n          -  Adults\n\n        Exclusion Criteria:\n\n          -  Children\n\n          -  Pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "16 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01858246", 
            "org_study_id": "SJPSMH01"
        }, 
        "intervention": [
            {
                "arm_group_label": "Bonebridge", 
                "intervention_name": "Bonebridge", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Bone Anchored Hearing Aid", 
                "intervention_name": "Bone Anchored Hearing Aid", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Hearing Loss, Conductive", 
            "Bone Conduction", 
            "bone conduction thresholds better than 45 dBHL"
        ], 
        "lastchanged_date": "May 4, 2014", 
        "location": {
            "contact": {
                "email": "stephenemjones@nhs.net", 
                "last_name": "Stephen EM Jones, MBBS, FRCS", 
                "phone": "+44 (0) 1382 660111", 
                "phone_ext": "32162"
            }, 
            "facility": {
                "address": {
                    "city": "Dundee", 
                    "country": "United Kingdom", 
                    "zip": "DD1 9SY"
                }, 
                "name": "Ninewells Hospital and Medical School"
            }, 
            "investigator": [
                {
                    "last_name": "Stephen EM Jones, MBBS, FRCS", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Patrick M Spielmann", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Musheer Hussain", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Samantha Batty", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomised Controlled Trial Comparing Bone Anchored Hearing Aid With Bonebridge", 
        "overall_official": {
            "affiliation": "NHS Tayside", 
            "last_name": "Stephen EM Jones", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Research Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "We will record and compare the standard speech audiometry results at a specific sound level in order to make a direct comparison of devices", 
            "measure": "Speech audiogram result at 6 months after switch on at 60 dBA in quiet using AB word lists", 
            "safety_issue": "No", 
            "time_frame": "Up to 1 year post-operatively"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01858246"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ninewells Hospital", 
            "investigator_full_name": "Stephen Jones", 
            "investigator_title": "Consultant ENT Surgeon", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "The speech audiogram will also be carried out in noise to demonstrate whether one device gives an appreciable advantage over another with respect to understanding in noise compared to silence.", 
                "measure": "Speech audiogram result at 60 dB A in noise using AB word lists", 
                "safety_issue": "No", 
                "time_frame": "Up to 1 year after implantation"
            }, 
            {
                "description": "Patients will be asked to complete the Glasgow Benefit Inventory (GBI) and Hearing Device Satisfaction Scale (HDSS) questionnaires", 
                "measure": "Patient reported outcome data", 
                "safety_issue": "No", 
                "time_frame": "Up to 1 year following implantation"
            }, 
            {
                "description": "The time (measured in days) will be recorded from the date of implantation to the date of its switch-on.", 
                "measure": "Time from surgery to device switch-on", 
                "safety_issue": "No", 
                "time_frame": "Up to 3 months"
            }, 
            {
                "measure": "Number of patient episodes required during study period", 
                "safety_issue": "No", 
                "time_frame": "1 year from implantation"
            }, 
            {
                "description": "Measured in days, as judged subjectively by ENT medical and nursing staff", 
                "measure": "Time to complete wound healing", 
                "safety_issue": "No", 
                "time_frame": "Up to 3 months from implantation"
            }
        ], 
        "source": "Ninewells Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ninewells Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}